Detalles de la búsqueda
1.
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.
BMC Cancer
; 21(1): 761, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34210290
2.
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Lancet Oncol
; 21(7): 969-977, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32615110
3.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791688
4.
Diffuse cutaneous melanosis is an under-recognized sign with a poor prognosis in patients with melanoma.
Clin Exp Dermatol
; 48(4): 376-379, 2023 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36763749
5.
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Lancet Oncol
; 17(10): 1396-1408, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569442
6.
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Lancet
; 386(9990): 249-57, 2015 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26002111
7.
Enteral nutritional support of the critically ill older adult.
Crit Care Nurs Q
; 38(3): 253-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26039647
8.
Are we over-treating with checkpoint inhibitors?
Br J Cancer
; 121(8): 629-630, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527686
9.
Maintenance therapy in ovarian cancer.
Curr Opin Oncol
; 26(5): 521-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25033374
10.
Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with CTLA4-related hypophysitis.
Eur J Endocrinol
; 186(1): 83-93, 2021 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735371
11.
Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer.
Eur J Cancer
; 44(2): 251-6, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18155897
12.
The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies.
Gynecol Oncol
; 107(3): 413-9, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17942145
13.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
J Clin Oncol
; 33(20): 2279-87, 2015 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033801
14.
Biomarkers in the development of anti-angiogenic therapies for ovarian cancer.
Cancer Treat Rev
; 38(6): 662-72, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22209539
15.
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.
Eur J Cancer
; 48(5): 703-12, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22036088
Resultados
1 -
15
de 15
1
Próxima >
>>